Literature DB >> 19372187

Measurement and quality control issues in multiplex protein assays: a case study.

Allison A Ellington1, Iftikhar J Kullo, Kent R Bailey, George G Klee.   

Abstract

BACKGROUND: Multiplex arrays are increasingly used for measuring protein biomarkers. Advantages of this approach include specimen conservation, limited sample handling, and decreased time and cost, but the challenges of optimizing assay format for each protein, selecting common dilution factors, and establishing robust quality control algorithms are substantial. Here, we use measurements of 15 protein biomarkers from a large study to illustrate processing, analytic, and quality control issues with multiplexed immunoassays.
METHODS: We contracted with ThermoScientific for duplicate measurements of 15 proteins in 2322 participants from a community-based cohort, a plasma control, and recombinant protein controls using 2 custom planar microarrays with 6 (panel A) or 9 (panel B) capture antibodies printed in each well. We selected constituent analytes in each panel based on endogenous concentrations and assay availability. Protocols were standardized for sample processing, storage, and freeze-thaw exposures. We analyzed data for effects of deviations from processing protocols, precision, and bias.
RESULTS: Measurements were within reportable ranges for each of the assays; however, concentrations for 7 of the 15 proteins were not centered on the dose-response curves. An additional freeze-thaw cycle and erroneous sample dilution for a subset of samples produced significantly different results. Measurements with large differences between duplicates were seen to cluster by analyte, plate, and participant. Conventional univariate quality control algorithms rejected many plates. Plate-specific medians of cohort and plasma control data significantly covaried, an observation important for development of alternative quality control algorithms.
CONCLUSIONS: Multiplex measurements present difficult challenges that require further analytical and statistical developments.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19372187      PMCID: PMC2965639          DOI: 10.1373/clinchem.2008.120717

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  15 in total

1.  Validation of immunoassays for bioanalysis: a pharmaceutical industry perspective.

Authors:  J W Findlay; W C Smith; J W Lee; G D Nordblom; I Das; B S DeSilva; M N Khan; R R Bowsher
Journal:  J Pharm Biomed Anal       Date:  2000-01       Impact factor: 3.935

2.  Multi-center genetic study of hypertension: The Family Blood Pressure Program (FBPP).

Authors: 
Journal:  Hypertension       Date:  2002-01       Impact factor: 10.190

Review 3.  Measuring proteins on microarrays.

Authors:  Barry Schweitzer; Stephen F Kingsmore
Journal:  Curr Opin Biotechnol       Date:  2002-02       Impact factor: 9.740

4.  Protein microarray platforms for clinical proteomics.

Authors:  Harvey B Pollard; Meera Srivastava; Ofer Eidelman; Catherine Jozwik; Stephen W Rothwell; Gregory P Mueller; David M Jacobowitz; Thomas Darling; William B Guggino; Jerry Wright; Pamela L Zeitlin; Cloud P Paweletz
Journal:  Proteomics Clin Appl       Date:  2007-08-10       Impact factor: 3.494

5.  The External RNA Controls Consortium: a progress report.

Authors:  Shawn C Baker; Steven R Bauer; Richard P Beyer; James D Brenton; Bud Bromley; John Burrill; Helen Causton; Michael P Conley; Rosalie Elespuru; Michael Fero; Carole Foy; James Fuscoe; Xiaolian Gao; David Lee Gerhold; Patrick Gilles; Federico Goodsaid; Xu Guo; Joe Hackett; Richard D Hockett; Pranvera Ikonomi; Rafael A Irizarry; Ernest S Kawasaki; Tamma Kaysser-Kranich; Kathleen Kerr; Gretchen Kiser; Walter H Koch; Kathy Y Lee; Chunmei Liu; Z Lewis Liu; Anne Lucas; Chitra F Manohar; Garry Miyada; Zora Modrusan; Helen Parkes; Raj K Puri; Laura Reid; Thomas B Ryder; Marc Salit; Raymond R Samaha; Uwe Scherf; Timothy J Sendera; Robert A Setterquist; Leming Shi; Richard Shippy; Jesus V Soriano; Elizabeth A Wagar; Janet A Warrington; Mickey Williams; Frederike Wilmer; Mike Wilson; Paul K Wolber; Xiaoning Wu; Renata Zadro
Journal:  Nat Methods       Date:  2005-10       Impact factor: 28.547

Review 6.  Protein biomarker discovery and validation: the long and uncertain path to clinical utility.

Authors:  Nader Rifai; Michael A Gillette; Steven A Carr
Journal:  Nat Biotechnol       Date:  2006-08       Impact factor: 54.908

7.  The MicroArray Quality Control (MAQC) project shows inter- and intraplatform reproducibility of gene expression measurements.

Authors:  Leming Shi; Laura H Reid; Wendell D Jones; Richard Shippy; Janet A Warrington; Shawn C Baker; Patrick J Collins; Francoise de Longueville; Ernest S Kawasaki; Kathleen Y Lee; Yuling Luo; Yongming Andrew Sun; James C Willey; Robert A Setterquist; Gavin M Fischer; Weida Tong; Yvonne P Dragan; David J Dix; Felix W Frueh; Frederico M Goodsaid; Damir Herman; Roderick V Jensen; Charles D Johnson; Edward K Lobenhofer; Raj K Puri; Uwe Schrf; Jean Thierry-Mieg; Charles Wang; Mike Wilson; Paul K Wolber; Lu Zhang; Shashi Amur; Wenjun Bao; Catalin C Barbacioru; Anne Bergstrom Lucas; Vincent Bertholet; Cecilie Boysen; Bud Bromley; Donna Brown; Alan Brunner; Roger Canales; Xiaoxi Megan Cao; Thomas A Cebula; James J Chen; Jing Cheng; Tzu-Ming Chu; Eugene Chudin; John Corson; J Christopher Corton; Lisa J Croner; Christopher Davies; Timothy S Davison; Glenda Delenstarr; Xutao Deng; David Dorris; Aron C Eklund; Xiao-hui Fan; Hong Fang; Stephanie Fulmer-Smentek; James C Fuscoe; Kathryn Gallagher; Weigong Ge; Lei Guo; Xu Guo; Janet Hager; Paul K Haje; Jing Han; Tao Han; Heather C Harbottle; Stephen C Harris; Eli Hatchwell; Craig A Hauser; Susan Hester; Huixiao Hong; Patrick Hurban; Scott A Jackson; Hanlee Ji; Charles R Knight; Winston P Kuo; J Eugene LeClerc; Shawn Levy; Quan-Zhen Li; Chunmei Liu; Ying Liu; Michael J Lombardi; Yunqing Ma; Scott R Magnuson; Botoul Maqsodi; Tim McDaniel; Nan Mei; Ola Myklebost; Baitang Ning; Natalia Novoradovskaya; Michael S Orr; Terry W Osborn; Adam Papallo; Tucker A Patterson; Roger G Perkins; Elizabeth H Peters; Ron Peterson; Kenneth L Philips; P Scott Pine; Lajos Pusztai; Feng Qian; Hongzu Ren; Mitch Rosen; Barry A Rosenzweig; Raymond R Samaha; Mark Schena; Gary P Schroth; Svetlana Shchegrova; Dave D Smith; Frank Staedtler; Zhenqiang Su; Hongmei Sun; Zoltan Szallasi; Zivana Tezak; Danielle Thierry-Mieg; Karol L Thompson; Irina Tikhonova; Yaron Turpaz; Beena Vallanat; Christophe Van; Stephen J Walker; Sue Jane Wang; Yonghong Wang; Russ Wolfinger; Alex Wong; Jie Wu; Chunlin Xiao; Qian Xie; Jun Xu; Wen Yang; Liang Zhang; Sheng Zhong; Yaping Zong; William Slikker
Journal:  Nat Biotechnol       Date:  2006-09       Impact factor: 54.908

8.  Gene expression profiling predicts clinical outcome of breast cancer.

Authors:  Laura J van 't Veer; Hongyue Dai; Marc J van de Vijver; Yudong D He; Augustinus A M Hart; Mao Mao; Hans L Peterse; Karin van der Kooy; Matthew J Marton; Anke T Witteveen; George J Schreiber; Ron M Kerkhoven; Chris Roberts; Peter S Linsley; René Bernards; Stephen H Friend
Journal:  Nature       Date:  2002-01-31       Impact factor: 49.962

9.  Simultaneous detection of eight analytes in human serum by two commercially available platforms for multiplex cytokine analysis.

Authors:  Gary Toedter; Karen Hayden; Carrie Wagner; Carrie Brodmerkel
Journal:  Clin Vaccine Immunol       Date:  2007-11-14

10.  Validating a custom multiplex ELISA against individual commercial immunoassays using clinical samples.

Authors:  Michael Liew; Matthew C Groll; James E Thompson; Sara L Call; Joann E Moser; Justin D Hoopes; Karl Voelkerding; Carl Wittwer; Rex S Spendlove
Journal:  Biotechniques       Date:  2007-03       Impact factor: 1.993

View more
  28 in total

1.  Accuracy and reproducibility of a multiplex immunoassay platform: a validation study.

Authors:  Julie A Bastarache; Tatsuki Koyama; Nancy E Wickersham; Daphne B Mitchell; Ray L Mernaugh; Lorraine B Ware
Journal:  J Immunol Methods       Date:  2011-01-26       Impact factor: 2.303

2.  Multiplexed method to calibrate and quantitate fluorescence signal for allergen-specific IgE.

Authors:  Margo R Monroe; Alexander P Reddington; Austin D Collins; Craig LaBoda; Marina Cretich; Marcella Chiari; Frédéric F Little; M Selim Unlü
Journal:  Anal Chem       Date:  2011-11-22       Impact factor: 6.986

3.  Sequential multiplexed analyte quantification using peptide immunoaffinity enrichment coupled to mass spectrometry.

Authors:  Jeffrey R Whiteaker; Lei Zhao; Chenwei Lin; Ping Yan; Pei Wang; Amanda G Paulovich
Journal:  Mol Cell Proteomics       Date:  2011-12-27       Impact factor: 5.911

4.  Validation of a multiplex electrochemiluminescent immunoassay platform in human and mouse samples.

Authors:  J A Bastarache; T Koyama; N E Wickersham; L B Ware
Journal:  J Immunol Methods       Date:  2014-04-21       Impact factor: 2.303

5.  Pre-analytical effects of blood sampling and handling in quantitative immunoassays for rheumatoid arthritis.

Authors:  Xiaoyan Zhao; Ferhan Qureshi; P Scott Eastman; William C Manning; Claire Alexander; William H Robinson; Lyndal K Hesterberg
Journal:  J Immunol Methods       Date:  2012-02-17       Impact factor: 2.303

Review 6.  Early identification of cardiovascular risk using genomics and proteomics.

Authors:  Iftikhar J Kullo; Leslie T Cooper
Journal:  Nat Rev Cardiol       Date:  2010-05-04       Impact factor: 32.419

Review 7.  Translating pharmacodynamic biomarkers from bench to bedside: analytical validation and fit-for-purpose studies to qualify multiplex immunofluorescent assays for use on clinical core biopsy specimens.

Authors:  Allison Marrero; Scott Lawrence; Deborah Wilsker; Andrea Regier Voth; Robert J Kinders
Journal:  Semin Oncol       Date:  2016-06-14       Impact factor: 4.929

Review 8.  Antibody-based protein multiplex platforms: technical and operational challenges.

Authors:  Allison A Ellington; Iftikhar J Kullo; Kent R Bailey; George G Klee
Journal:  Clin Chem       Date:  2009-12-03       Impact factor: 8.327

9.  Sex and ethnic differences in 47 candidate proteomic markers of cardiovascular disease: the Mayo Clinic proteomic markers of arteriosclerosis study.

Authors:  Charles X Kim; Kent R Bailey; George G Klee; Allison A Ellington; Guanghui Liu; Thomas H Mosley; Hamid Rehman; Iftikhar J Kullo
Journal:  PLoS One       Date:  2010-02-05       Impact factor: 3.240

Review 10.  Blood cytokines as biomarkers of in vivo toxicity in preclinical safety assessment: considerations for their use.

Authors:  Jacqueline M Tarrant
Journal:  Toxicol Sci       Date:  2010-05-06       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.